Skip to main content
. Author manuscript; available in PMC: 2024 Oct 24.
Published in final edited form as: SM J Nephrol Kidney Dis. 2024 Aug 21;5(1):7.

Table 1.

One Year Follow-up on Baseline Sample of Adult PD Patients

Clinical
Outcome
Overall Death PD --> HD Transplant Maintain PD p-value
N = 100 N = 12 N = 12 N = 10 N = 66
Total follow-up time (days)
mean (SD)
300 (112) 172 (100) 192 (139) 161 (112) 363 (16)
Baseline Demographics
Age (yrs): mean (SD) 51.8 (17.0) 56.3 (15.9) 51.3 (14.6) 39.2 (14.2) 53.0 (17.3) 0.080
Gender (male) 57 (57.0%) 9 (75.0%) 7 (58.3%) 5 (50.0%) 36 (54.5%) 0.594
Race (%) 0.868
African American 31 (31.0%) 4 (33.3%) 5 (41.7%) 4 (40.0%) 18 (27.3%)
Hispanic 4 (4%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 4 (6.1%)
Southeast Asian 1 (1%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 1 (1.5%)
White American 64 (64.0%) 8 (66.7%) 7 (58.3%) 6 (60.0%) 43 (65.2%)
90-day Incident (%) 23 (23.0%) 1 (8.3%) 4 (33.3%) 1 (10.0%) 17 (25.8%) 0.363
Prevalent (%) 77 (77.0%) 11 (91.7%) 8 (66.7%) 9 (90.0%) 49 (74.2%)
Vintage (days): mean (SD) 571 (584) 900 (799) 474 (692) 537 (371) 553 (537) 0.218
Baseline Comorbid Conditions
Diabetes mellitus (%) 46(46.0%) 8 (66.7%) 5 (41.7%) 1 (10.0%) 32(48.5%) 0.062
Hypertension (%) 85 (85.0%) 9 (75.0%) 9 (75.0%) 9 (90.0%) 58 (87.9%) 0.516
Cardiac disease (%) 32 (32.0%) 8 (66.7%) 2 (16.7%) 0 (0.0%) 22 (33.3%) 0.004
Malignancy (%) 19 (19.0%) 1 (8.3%) 3 (25.0%) 3 (30.0%) 12 (18.2%)) 0.578
Depression/Anxiety (%) 37 (37%) 5 (41.7%) 3 (25%) 3 (30%) 26 (39.4%) 0.762
Albumin: mean (SD) 3.5 (0.49) 3.0 (0.48) 3.3 (0.44) 3.6 (0.42) 3.6 (0.45) < .001
Davies Comorbidity Score 1.19 (1.07) 1.92 (1.24) 1.00 (0.85) 0.40 (0.52) 1.21 (1.06) 0.008
Psychosocial Measurements
Mindset Scale: mean (SD) 12.77 (4.2) 10 (5.2) 13 (4.2) 15 (2.1) 12.89 (4.1) 0.042
Health Literacy: mean (SD) 12.54 (2.7) 11.08 (3.3) 13.58 (2.9) 12.70 (1.8) 12.59 (2.7) 0.159
Health Self-Efficacy (SD) 13.3 (3.3) 11.6 (3.1) 13.6 (3.8) 13.9 (2.4) 13.4 (3.3) 0.300